hotspot -WSS

hotspot

author：hotspot 2025-09-27 16:23:49 - browse：237

WASHINGTON — For those already felled by fumes from the Brazilian Blowout, it might be small consolation, but lawmakers are pushing ahead with a campaign for better oversight of the beauty business.

Despite its booming growth, the cosmetics industry in the US has been virtually unregulated. The Food, Drug, and Cosmetic Act, adopted in 1938, essentially allowed personal care product companies to self-police.

But rising public concern over bad reactions to makeup, hair dyes, and fragrances, as well as evidence of long-term health risks from some of their chemical contents, has led lawmakers to try to toughen the regulatory framework for the $60 billion enhancement industry.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Trump Organization, Michael Cohen agree to settle million

entertainment

WSS

Grand jury probing Trump's efforts to overturn 2020 election did not meet Friday: Sources

Patients, doctors are clashing about side effects of hormonal birth control

Biden administration plans revamp of organ transplant system

What is the Turing Test that determines if computers can think?

The thinking behind the controversial eating disorder chatbot Tessa

What is artificial intelligence? Experts weigh in

hotspot

hotspot

focus

How to save PrEP access — and even expand it

Pfizer's RSV vaccine recommended for approval in Europe

Novavax promises a turnaround & Lilly roils the obesity market

Dispute over threat of extinction posed by artificial intelligence looms over surging industry

Anesthesiologist group: stop taking Ozempic before surgery

How Brent Saunders' Allergan experiment failed

Duchenne breakthrough therapy leaves behind pioneering families

Study: Misdiagnosis causes 800,000 deaths, serious disabilities a year in U.S.

23andMe had bad news about my health. I wish a person had delivered it

Senate panel passes drug pricing bills, but drops one PBM reform

hotspot

It's time to take a new tack for treating Alzheimer's

A former Republican legislative candidate has been charged for his role in the US Capitol riot

Hey, doctors: Don't be no

How Brent Saunders' Allergan experiment failed

Xenotransplantation trials will require adjusting expectations, experts say

Why Marc Tessier

explore

focus

entertainment

leisure time